Cadonilimab
Drug timelines are a Plus or Pro feature.
90 regulatory and trial events tracked for Cadonilimab, covering 2022-12-19 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma [Phase 2]